0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amebiasis Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-38D9688
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Amebiasis Market Insights Forecast to 2028
BUY CHAPTERS

Global Amebiasis Market Insights, Forecast to 2030

Code: QYRE-Auto-38D9688
Report
December 2024
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Amebiasis Market Size

The global Amebiasis market is projected to grow from US$ 928 million in 2024 to US$ 1323.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.

Amebiasis Market

Amebiasis Market

Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain.
Market Analysis and Insights: Global Amebiasis Market
The amebiasis drugs market is driven by the high burden of amebiasis infections, caused by the parasite Entamoeba histolytica, especially in developing regions with poor sanitation and healthcare facilities. Amebiasis can lead to severe gastrointestinal symptoms and potentially life-threatening complications. The increasing prevalence and severity of the disease have contributed to the demand for effective drugs to treat and manage amebiasis. Additionally, advancements in medical research and drug development have led to the introduction of new and improved therapies for better patient outcomes. However, challenges include the need for early diagnosis and proper management to prevent complications, potential drug resistance, and limited access to healthcare in some regions. Overcoming these challenges through increased awareness, affordable treatment options, and improved healthcare infrastructure will be crucial for the sustained growth of the amebiasis drugs market.
Report Covers:
This report presents an overview of global market for Amebiasis market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Amebiasis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Amebiasis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Amebiasis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Amebiasis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Amebiasis revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Amebiasis Market Report

Report Metric Details
Report Name Amebiasis Market
Accounted market size in 2024 US$ 928 million
Forecasted market size in 2030 US$ 1323.9 million
CAGR 6.1
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corporation, Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Sanofi, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Sun Pharmaceutical, Heritage Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Amebiasis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Amebiasis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amebiasis revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Amebiasis Market growing?

Ans: The Amebiasis Market witnessing a CAGR of 6.1 during the forecast period 2025-2030.

What is the Amebiasis Market size in 2030?

Ans: The Amebiasis Market size in 2030 will be US$ 1323.9 million.

Who are the main players in the Amebiasis Market report?

Ans: The main players in the Amebiasis Market are Dr. Reddy’s Laboratories, Mission Pharmacal, Aceto Corporation, Mylan Pharmaceuticals, Impax Laboratories, Pfizer, Sanofi, Lupin Pharmaceuticals, Glenmark Pharmaceuticals, Sun Pharmaceutical, Heritage Pharmaceuticals

What are the Application segmentation covered in the Amebiasis Market report?

Ans: The Applications covered in the Amebiasis Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Amebiasis Market report?

Ans: The Types covered in the Amebiasis Market report are Metronidazole, Paromomycin, Tinidazole, Other

Recommended Reports

Antiparasitic Drugs

Gastrointestinal Disorders

Veterinary Deworming

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amebiasis Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Metronidazole
1.2.3 Paromomycin
1.2.4 Tinidazole
1.2.5 Other
1.3 Market by Application
1.3.1 Global Amebiasis Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Amebiasis Market Perspective (2019-2030)
2.2 Global Amebiasis Growth Trends by Region
2.2.1 Amebiasis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Amebiasis Historic Market Size by Region (2019-2024)
2.2.3 Amebiasis Forecasted Market Size by Region (2025-2030)
2.3 Amebiasis Market Dynamics
2.3.1 Amebiasis Industry Trends
2.3.2 Amebiasis Market Drivers
2.3.3 Amebiasis Market Challenges
2.3.4 Amebiasis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Amebiasis by Players
3.1.1 Global Amebiasis Revenue by Players (2019-2024)
3.1.2 Global Amebiasis Revenue Market Share by Players (2019-2024)
3.2 Global Amebiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Amebiasis, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Amebiasis Market Concentration Ratio
3.4.1 Global Amebiasis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amebiasis Revenue in 2023
3.5 Global Key Players of Amebiasis Head office and Area Served
3.6 Global Key Players of Amebiasis, Product and Application
3.7 Global Key Players of Amebiasis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Amebiasis Breakdown Data by Type
4.1 Global Amebiasis Historic Market Size by Type (2019-2024)
4.2 Global Amebiasis Forecasted Market Size by Type (2025-2030)
5 Amebiasis Breakdown Data by Application
5.1 Global Amebiasis Historic Market Size by Application (2019-2024)
5.2 Global Amebiasis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Amebiasis Market Size (2019-2030)
6.2 North America Amebiasis Market Size by Type
6.2.1 North America Amebiasis Market Size by Type (2019-2024)
6.2.2 North America Amebiasis Market Size by Type (2025-2030)
6.2.3 North America Amebiasis Market Share by Type (2019-2030)
6.3 North America Amebiasis Market Size by Application
6.3.1 North America Amebiasis Market Size by Application (2019-2024)
6.3.2 North America Amebiasis Market Size by Application (2025-2030)
6.3.3 North America Amebiasis Market Share by Application (2019-2030)
6.4 North America Amebiasis Market Size by Country
6.4.1 North America Amebiasis Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Amebiasis Market Size by Country (2019-2024)
6.4.3 North America Amebiasis Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Amebiasis Market Size (2019-2030)
7.2 Europe Amebiasis Market Size by Type
7.2.1 Europe Amebiasis Market Size by Type (2019-2024)
7.2.2 Europe Amebiasis Market Size by Type (2025-2030)
7.2.3 Europe Amebiasis Market Share by Type (2019-2030)
7.3 Europe Amebiasis Market Size by Application
7.3.1 Europe Amebiasis Market Size by Application (2019-2024)
7.3.2 Europe Amebiasis Market Size by Application (2025-2030)
7.3.3 Europe Amebiasis Market Share by Application (2019-2030)
7.4 Europe Amebiasis Market Size by Country
7.4.1 Europe Amebiasis Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Amebiasis Market Size by Country (2019-2024)
7.4.3 Europe Amebiasis Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Amebiasis Market Size (2019-2030)
8.2 China Amebiasis Market Size by Type
8.2.1 China Amebiasis Market Size by Type (2019-2024)
8.2.2 China Amebiasis Market Size by Type (2025-2030)
8.2.3 China Amebiasis Market Share by Type (2019-2030)
8.3 China Amebiasis Market Size by Application
8.3.1 China Amebiasis Market Size by Application (2019-2024)
8.3.2 China Amebiasis Market Size by Application (2025-2030)
8.3.3 China Amebiasis Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Amebiasis Market Size (2019-2030)
9.2 Asia Amebiasis Market Size by Type
9.2.1 Asia Amebiasis Market Size by Type (2019-2024)
9.2.2 Asia Amebiasis Market Size by Type (2025-2030)
9.2.3 Asia Amebiasis Market Share by Type (2019-2030)
9.3 Asia Amebiasis Market Size by Application
9.3.1 Asia Amebiasis Market Size by Application (2019-2024)
9.3.2 Asia Amebiasis Market Size by Application (2025-2030)
9.3.3 Asia Amebiasis Market Share by Application (2019-2030)
9.4 Asia Amebiasis Market Size by Region
9.4.1 Asia Amebiasis Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Amebiasis Market Size by Region (2019-2024)
9.4.3 Asia Amebiasis Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Amebiasis Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Amebiasis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Amebiasis Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Amebiasis Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Amebiasis Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Amebiasis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Amebiasis Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Amebiasis Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Amebiasis Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Amebiasis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Amebiasis Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Amebiasis Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Amebiasis Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Dr. Reddy’s Laboratories
11.1.1 Dr. Reddy’s Laboratories Company Details
11.1.2 Dr. Reddy’s Laboratories Business Overview
11.1.3 Dr. Reddy’s Laboratories Amebiasis Introduction
11.1.4 Dr. Reddy’s Laboratories Revenue in Amebiasis Business (2019-2024)
11.1.5 Dr. Reddy’s Laboratories Recent Developments
11.2 Mission Pharmacal
11.2.1 Mission Pharmacal Company Details
11.2.2 Mission Pharmacal Business Overview
11.2.3 Mission Pharmacal Amebiasis Introduction
11.2.4 Mission Pharmacal Revenue in Amebiasis Business (2019-2024)
11.2.5 Mission Pharmacal Recent Developments
11.3 Aceto Corporation
11.3.1 Aceto Corporation Company Details
11.3.2 Aceto Corporation Business Overview
11.3.3 Aceto Corporation Amebiasis Introduction
11.3.4 Aceto Corporation Revenue in Amebiasis Business (2019-2024)
11.3.5 Aceto Corporation Recent Developments
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Company Details
11.4.2 Mylan Pharmaceuticals Business Overview
11.4.3 Mylan Pharmaceuticals Amebiasis Introduction
11.4.4 Mylan Pharmaceuticals Revenue in Amebiasis Business (2019-2024)
11.4.5 Mylan Pharmaceuticals Recent Developments
11.5 Impax Laboratories
11.5.1 Impax Laboratories Company Details
11.5.2 Impax Laboratories Business Overview
11.5.3 Impax Laboratories Amebiasis Introduction
11.5.4 Impax Laboratories Revenue in Amebiasis Business (2019-2024)
11.5.5 Impax Laboratories Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Amebiasis Introduction
11.6.4 Pfizer Revenue in Amebiasis Business (2019-2024)
11.6.5 Pfizer Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Amebiasis Introduction
11.7.4 Sanofi Revenue in Amebiasis Business (2019-2024)
11.7.5 Sanofi Recent Developments
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Company Details
11.8.2 Lupin Pharmaceuticals Business Overview
11.8.3 Lupin Pharmaceuticals Amebiasis Introduction
11.8.4 Lupin Pharmaceuticals Revenue in Amebiasis Business (2019-2024)
11.8.5 Lupin Pharmaceuticals Recent Developments
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Company Details
11.9.2 Glenmark Pharmaceuticals Business Overview
11.9.3 Glenmark Pharmaceuticals Amebiasis Introduction
11.9.4 Glenmark Pharmaceuticals Revenue in Amebiasis Business (2019-2024)
11.9.5 Glenmark Pharmaceuticals Recent Developments
11.10 Sun Pharmaceutical
11.10.1 Sun Pharmaceutical Company Details
11.10.2 Sun Pharmaceutical Business Overview
11.10.3 Sun Pharmaceutical Amebiasis Introduction
11.10.4 Sun Pharmaceutical Revenue in Amebiasis Business (2019-2024)
11.10.5 Sun Pharmaceutical Recent Developments
11.11 Heritage Pharmaceuticals
11.11.1 Heritage Pharmaceuticals Company Details
11.11.2 Heritage Pharmaceuticals Business Overview
11.11.3 Heritage Pharmaceuticals Amebiasis Introduction
11.11.4 Heritage Pharmaceuticals Revenue in Amebiasis Business (2019-2024)
11.11.5 Heritage Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Amebiasis Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Metronidazole
    Table 3. Key Players of Paromomycin
    Table 4. Key Players of Tinidazole
    Table 5. Key Players of Other
    Table 6. Global Amebiasis Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Amebiasis Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Amebiasis Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Amebiasis Market Share by Region (2019-2024)
    Table 10. Global Amebiasis Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Amebiasis Market Share by Region (2025-2030)
    Table 12. Amebiasis Market Trends
    Table 13. Amebiasis Market Drivers
    Table 14. Amebiasis Market Challenges
    Table 15. Amebiasis Market Restraints
    Table 16. Global Amebiasis Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Amebiasis Revenue Share by Players (2019-2024)
    Table 18. Global Top Amebiasis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis as of 2023)
    Table 19. Global Amebiasis Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Amebiasis Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Amebiasis, Headquarters and Area Served
    Table 22. Global Key Players of Amebiasis, Product and Application
    Table 23. Global Key Players of Amebiasis, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Amebiasis Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Amebiasis Revenue Market Share by Type (2019-2024)
    Table 27. Global Amebiasis Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Amebiasis Revenue Market Share by Type (2025-2030)
    Table 29. Global Amebiasis Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Amebiasis Revenue Share by Application (2019-2024)
    Table 31. Global Amebiasis Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Amebiasis Revenue Share by Application (2025-2030)
    Table 33. North America Amebiasis Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Amebiasis Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Amebiasis Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Amebiasis Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Amebiasis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Amebiasis Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Amebiasis Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Amebiasis Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Amebiasis Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Amebiasis Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Amebiasis Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Amebiasis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Amebiasis Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Amebiasis Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Amebiasis Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Amebiasis Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Amebiasis Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Amebiasis Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Amebiasis Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Amebiasis Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Amebiasis Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Amebiasis Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Amebiasis Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Amebiasis Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Amebiasis Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Amebiasis Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Amebiasis Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Amebiasis Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Amebiasis Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Amebiasis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Amebiasis Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Amebiasis Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Dr. Reddy’s Laboratories Company Details
    Table 66. Dr. Reddy’s Laboratories Business Overview
    Table 67. Dr. Reddy’s Laboratories Amebiasis Product
    Table 68. Dr. Reddy’s Laboratories Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 69. Dr. Reddy’s Laboratories Recent Developments
    Table 70. Mission Pharmacal Company Details
    Table 71. Mission Pharmacal Business Overview
    Table 72. Mission Pharmacal Amebiasis Product
    Table 73. Mission Pharmacal Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 74. Mission Pharmacal Recent Developments
    Table 75. Aceto Corporation Company Details
    Table 76. Aceto Corporation Business Overview
    Table 77. Aceto Corporation Amebiasis Product
    Table 78. Aceto Corporation Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 79. Aceto Corporation Recent Developments
    Table 80. Mylan Pharmaceuticals Company Details
    Table 81. Mylan Pharmaceuticals Business Overview
    Table 82. Mylan Pharmaceuticals Amebiasis Product
    Table 83. Mylan Pharmaceuticals Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 84. Mylan Pharmaceuticals Recent Developments
    Table 85. Impax Laboratories Company Details
    Table 86. Impax Laboratories Business Overview
    Table 87. Impax Laboratories Amebiasis Product
    Table 88. Impax Laboratories Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 89. Impax Laboratories Recent Developments
    Table 90. Pfizer Company Details
    Table 91. Pfizer Business Overview
    Table 92. Pfizer Amebiasis Product
    Table 93. Pfizer Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 94. Pfizer Recent Developments
    Table 95. Sanofi Company Details
    Table 96. Sanofi Business Overview
    Table 97. Sanofi Amebiasis Product
    Table 98. Sanofi Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 99. Sanofi Recent Developments
    Table 100. Lupin Pharmaceuticals Company Details
    Table 101. Lupin Pharmaceuticals Business Overview
    Table 102. Lupin Pharmaceuticals Amebiasis Product
    Table 103. Lupin Pharmaceuticals Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 104. Lupin Pharmaceuticals Recent Developments
    Table 105. Glenmark Pharmaceuticals Company Details
    Table 106. Glenmark Pharmaceuticals Business Overview
    Table 107. Glenmark Pharmaceuticals Amebiasis Product
    Table 108. Glenmark Pharmaceuticals Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 109. Glenmark Pharmaceuticals Recent Developments
    Table 110. Sun Pharmaceutical Company Details
    Table 111. Sun Pharmaceutical Business Overview
    Table 112. Sun Pharmaceutical Amebiasis Product
    Table 113. Sun Pharmaceutical Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 114. Sun Pharmaceutical Recent Developments
    Table 115. Heritage Pharmaceuticals Company Details
    Table 116. Heritage Pharmaceuticals Business Overview
    Table 117. Heritage Pharmaceuticals Amebiasis Product
    Table 118. Heritage Pharmaceuticals Revenue in Amebiasis Business (2019-2024) & (US$ Million)
    Table 119. Heritage Pharmaceuticals Recent Developments
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Amebiasis Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Amebiasis Market Share by Type: 2023 VS 2030
    Figure 3. Metronidazole Features
    Figure 4. Paromomycin Features
    Figure 5. Tinidazole Features
    Figure 6. Other Features
    Figure 7. Global Amebiasis Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Amebiasis Market Share by Application: 2023 VS 2030
    Figure 9. Hospital Case Studies
    Figure 10. Pharmacy Case Studies
    Figure 11. Amebiasis Report Years Considered
    Figure 12. Global Amebiasis Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Amebiasis Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Amebiasis Market Share by Region: 2023 VS 2030
    Figure 15. Global Amebiasis Market Share by Players in 2023
    Figure 16. Global Top Amebiasis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amebiasis as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Amebiasis Revenue in 2023
    Figure 18. North America Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Amebiasis Market Share by Type (2019-2030)
    Figure 20. North America Amebiasis Market Share by Application (2019-2030)
    Figure 21. North America Amebiasis Market Share by Country (2019-2030)
    Figure 22. United States Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Amebiasis Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Amebiasis Market Share by Type (2019-2030)
    Figure 26. Europe Amebiasis Market Share by Application (2019-2030)
    Figure 27. Europe Amebiasis Market Share by Country (2019-2030)
    Figure 28. Germany Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Amebiasis Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Amebiasis Market Share by Type (2019-2030)
    Figure 36. China Amebiasis Market Share by Application (2019-2030)
    Figure 37. Asia Amebiasis Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Amebiasis Market Share by Type (2019-2030)
    Figure 39. Asia Amebiasis Market Share by Application (2019-2030)
    Figure 40. Asia Amebiasis Market Share by Region (2019-2030)
    Figure 41. Japan Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Amebiasis Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Amebiasis Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Amebiasis Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Amebiasis Market Share by Country (2019-2030)
    Figure 51. Brazil Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Amebiasis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Dr. Reddy’s Laboratories Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 58. Mission Pharmacal Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 59. Aceto Corporation Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 60. Mylan Pharmaceuticals Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 61. Impax Laboratories Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 62. Pfizer Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 63. Sanofi Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 64. Lupin Pharmaceuticals Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 65. Glenmark Pharmaceuticals Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 66. Sun Pharmaceutical Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 67. Heritage Pharmaceuticals Revenue Growth Rate in Amebiasis Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart